Barbara Klencke
2019
In 2019, Barbara Klencke earned a total compensation of $971.4K as Chief Development Officer at ProNAi Therapeutics, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $184,737 |
|---|---|
| Option Awards | $297,710 |
| Salary | $486,150 |
| Other | $2,800 |
| Total | $971,397 |
Klencke received $486.2K in salary, accounting for 50% of the total pay in 2019.
Klencke also received $184.7K in non-equity incentive plan, $297.7K in option awards and $2.8K in other compensation.
Rankings
In 2019, Barbara Klencke's compensation ranked 9,399th out of 13,971 executives tracked by ExecPay. In other words, Klencke earned more than 32.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,399 out of 13,971 | 33rd |
Division Manufacturing | 3,772 out of 5,701 | 34th |
Major group Chemicals And Allied Products | 1,432 out of 2,200 | 35th |
Industry group Drugs | 1,221 out of 1,886 | 35th |
Industry Pharmaceutical Preparations | 908 out of 1,398 | 35th |
Source: SEC filing on April 24, 2020.
Klencke's colleagues
We found two more compensation records of executives who worked with Barbara Klencke at ProNAi Therapeutics in 2019.